532815 Stock Overview
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
SMS Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹211.35 |
| 52 Week High | ₹219.30 |
| 52 Week Low | ₹75.10 |
| Beta | 1.18 |
| 1 Month Change | 15.81% |
| 3 Month Change | 70.72% |
| 1 Year Change | 152.54% |
| 3 Year Change | 36.97% |
| 5 Year Change | 249.05% |
| Change since IPO | 490.61% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532815 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 1.3% | -1.4% | -1.6% |
| 1Y | 152.5% | 53.7% | 45.0% |
Return vs Industry: 532815 exceeded the Indian Pharmaceuticals industry which returned 53.7% over the past year.
Return vs Market: 532815 exceeded the Indian Market which returned 45% over the past year.
Price Volatility
| 532815 volatility | |
|---|---|
| 532815 Average Weekly Movement | 9.9% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 532815's share price has been volatile over the past 3 months.
Volatility Over Time: 532815's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 1,095 | Ramesh Potluri | www.smspharma.com |
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, anti-epileptic, anti-psychotic, anti-inflammatory, anti-fungal, anti-viral, anti-coagulant, and anti-retroviral products. It is also involved in the contract research activities.
SMS Pharmaceuticals Limited Fundamentals Summary
| 532815 fundamental statistics | |
|---|---|
| Market cap | ₹18.13b |
| Earnings (TTM) | ₹360.58m |
| Revenue (TTM) | ₹6.13b |
49.6x
P/E Ratio2.9x
P/S RatioIs 532815 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532815 income statement (TTM) | |
|---|---|
| Revenue | ₹6.13b |
| Cost of Revenue | ₹4.22b |
| Gross Profit | ₹1.91b |
| Other Expenses | ₹1.55b |
| Earnings | ₹360.58m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.26 |
| Gross Margin | 31.16% |
| Net Profit Margin | 5.88% |
| Debt/Equity Ratio | 57.8% |
How did 532815 perform over the long term?
See historical performance and comparison